SCHEMBL3579302

SCHEMBL3579302

CS(=O)(=O)c1ccc(COc2cc(CC(=O)O)cc(-c3ccc(C(F)(F)F)cc3)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 9/20 0.56
PPARA Q07869 3/20 0.56
RXRA P19793 5/20 0.55
RXRB P28702 5/20 0.55
RXRG P48443 5/20 0.55
PTGDR2 Q9Y5Y4 1/20 0.53
ADAMTS4 O75173 1/20 0.52
MMP13 P45452 1/20 0.52
PPARG P37231 1/20 0.50
BCL2L1 Q07817 1/20 0.49
MCL1 Q07820 1/20 0.49
PSEN1 P49768 1/20 0.49
PSEN2 P49810 1/20 0.49
APH1B Q8WW43 1/20 0.49
NCSTN Q92542 1/20 0.49
APH1A Q96BI3 1/20 0.49
PSENEN Q9NZ42 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN6 P29350 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3574038 0.90 PPARD (0.67) PPARDPPARARXRARXRBRXRG
SCHEMBL3576533 0.89 PPARD (0.53) PPARDPPARARXRARXRBRXRG
SCHEMBL3574383 0.87 PPARD (0.63) PPARDPPARARXRARXRBRXRG
SCHEMBL3574622 0.87 LTB4R (0.51) PPARDPTGDR2ADAMTS4MMP13PPARG
SCHEMBL3573491 0.86 PPARD (0.62) PPARDPPARARXRARXRBRXRG
SCHEMBL478042 0.86 PPARD (0.65) PPARDPPARARXRARXRBRXRG
SCHEMBL3573400 0.85 PPARD (0.63) PPARDPPARARXRARXRBRXRG
SCHEMBL3571698 0.84 PPARD (0.51) PPARDPPARARXRARXRBRXRG
SCHEMBL3576259 0.84 PPARD (0.57) PPARDPPARARXRARXRBRXRG
SCHEMBL3569765 0.84 PPARD (0.63) PPARDPPARARXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805129-B1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME LTD (GB) 2009-03-18 EP claimed
EP-1805129-A1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME AG (DE) 2007-07-11 EP claimed
WO-2006045554-A1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME AG (DE) 2006-05-04 WO claimed
US-7825160-B2 such as [5-(4-Fluoro-benzyloxy)-4'-trifluoromethyl-biphenyl-3-yl]-acetic acid, used for the treatment of Alzheimer's disease and for the modulation of gamma -secretase activity CELLZOME LIMITED (GB) 2010-11-02 US disclosed
US-20090118289-A1 (Biphenyl) Carboxylic Acids and Derivatives Thereof CELLZOME AG (DE) 2009-05-07 US disclosed
EP-1805129-B1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME LTD (GB) 2009-03-18 EP disclosed
EP-1805129-A1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME AG (DE) 2007-07-11 EP disclosed
WO-2006045554-A1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME AG (DE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118289-A1 (Biphenyl) Carboxylic Acids and Derivatives Thereof BACE1, BACE2, APP PPARD 455/4885PPARA 327/4885RXRA 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.